IRIS UniCatt

Fresa, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.486
AS - Asia 1.382
EU - Europa 816
SA - Sud America 307
Continente sconosciuto - Info sul continente non disponibili 79
AF - Africa 30
OC - Oceania 1
Totale 4.101
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.424
SG - Singapore 615
CN - Cina 308
IT - Italia 271
BR - Brasile 240
VN - Vietnam 143
FR - Francia 109
DE - Germania 108
IN - India 79
SE - Svezia 79
FI - Finlandia 69
JP - Giappone 52
GB - Regno Unito 40
ID - Indonesia 38
CA - Canada 32
IE - Irlanda 31
AR - Argentina 29
KR - Corea 29
BD - Bangladesh 26
HK - Hong Kong 23
RU - Federazione Russa 22
MX - Messico 21
NL - Olanda 15
PL - Polonia 14
AT - Austria 12
EC - Ecuador 12
ZA - Sudafrica 11
CZ - Repubblica Ceca 10
IQ - Iraq 10
TR - Turchia 10
CO - Colombia 9
ES - Italia 9
NP - Nepal 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
DZ - Algeria 4
IL - Israele 4
UZ - Uzbekistan 4
VE - Venezuela 4
IR - Iran 3
JO - Giordania 3
KE - Kenya 3
PH - Filippine 3
PK - Pakistan 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
UA - Ucraina 3
AL - Albania 2
AZ - Azerbaigian 2
BB - Barbados 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CL - Cile 2
EG - Egitto 2
GR - Grecia 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
LT - Lituania 2
LV - Lettonia 2
MA - Marocco 2
MD - Moldavia 2
PE - Perù 2
PT - Portogallo 2
RO - Romania 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AU - Australia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
MC - Monaco 1
MR - Mauritania 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
SN - Senegal 1
TW - Taiwan 1
UY - Uruguay 1
Totale 4.025
Salva come PNG Salva come JPEG
Città #
Singapore 366
San Jose 192
Ashburn 178
Rome 98
Chandler 75
Hefei 73
New York 63
Beijing 57
Los Angeles 54
Hyderabad 52
Tokyo 51
Chicago 50
Ho Chi Minh City 47
Council Bluffs 44
Lauterbourg 43
Hanoi 42
Dallas 35
Florence 34
Frankfurt am Main 34
Jakarta 32
Munich 31
Dublin 29
Seoul 29
Milan 28
Helsinki 27
Santa Clara 24
Turku 23
Kent 21
Hong Kong 19
Lappeenranta 19
The Dalles 19
Atlanta 17
Buffalo 16
St Louis 16
São Paulo 16
Denver 15
Montreal 15
Nuremberg 15
Boardman 13
Rio de Janeiro 13
Brooklyn 12
Phoenix 12
Tampa 12
Boston 11
Moscow 11
Orem 11
Bremen 10
Elk Grove Village 10
Princeton 10
Salt Lake City 10
Marseille 9
Stockholm 9
Warsaw 9
Düsseldorf 8
Naples 8
Vienna 8
Washington 8
Johannesburg 7
London 7
Mexico City 7
Poplar 7
San Francisco 7
Amsterdam 6
Brno 6
Haiphong 6
San Mateo 6
Shanghai 6
Toronto 6
Tukwila 6
Wilmington 6
Belo Horizonte 5
Bogotá 5
Buenos Aires 5
Chennai 5
Da Nang 5
Dulles 5
Guayaquil 5
Houston 5
Manchester 5
North Hollywood 5
Paris 5
Pavia 5
Brasília 4
Brdo 4
Brussels 4
Bắc Giang 4
Campinas 4
Curitiba 4
Guangzhou 4
Juneau 4
Lancaster 4
Las Vegas 4
Manaus 4
New Delhi 4
Porto Alegre 4
Tashkent 4
Turin 4
Ankara 3
Arezzo 3
Baghdad 3
Totale 2.405
Salva come PNG Salva come JPEG
Nome #
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 189
Role of microRNAs in Chronic Lymphocytic Leukemia 160
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 148
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 139
Acute graft versus host disease 1976-2020: reduced incidence and predictive factors 136
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 132
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 130
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study 124
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia 116
COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody? 116
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 112
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study 111
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience 109
Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience 104
Richter transformation in Chronic Lymphocytic Leukemia 104
Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region 104
Treatment options for elderly/unfit patients with chronic lymphocytic leukemia in the era of targeted drugs: A comprehensive review 103
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study 102
Treatment Sequencing in Chronic Lymphocytic Leukemia in 2024: Where We Are and Where We Are Headed 98
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL 98
Do age, fitness and concomitant medications influence management and outcomes of CLL patients treated with ibrutinib? 94
The concomitance of lymphoma and breast carcinoma in the bone 94
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 93
Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B-cell lymphomas 93
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 92
Autoimmune hemolytic anemia in chronic lymphocytic leukemia: A comprehensive review 91
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis 90
VEGF and IL-6 Correlation in POEMS: A Potential Upcoming Marker of Active Disease and Early Autologous BMT Response 89
Relapsed/refractory pure red cell aplasia in chronic lymphocytic leukemia successfully treated with acalabrutinib: a case report and review of the literature 88
First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies 86
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience 83
Purging with chlorambucil to prevent infusion-related reaction before obinutuzumab administration: A monocentric pilot experience 83
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study 82
Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience 79
Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia 78
Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study 75
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study 73
CAR-T Cells in Chronic Lymphocytic Leukemia 71
Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control study 52
Venetoclax-based regimens in octogenarian patients with CLL: efficacy, safety, and comparison to BTKi in a multicenter cohort 48
Measurable residual disease in chronic lymphocytic leukemia 31
Clinical Outcomes in Double-Exposed Chronic Lymphocytic Leukemia Patients in Italy 1
Totale 4.101
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.580
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202270 0 0 3 2 5 0 1 7 3 0 33 16
2022/2023268 33 31 12 29 23 22 10 19 40 17 31 1
2023/2024342 6 60 20 34 14 49 29 21 2 26 30 51
2024/20251.024 20 19 53 52 56 37 35 26 88 117 359 162
2025/20262.205 281 93 174 279 327 136 351 127 129 167 72 69
2026/2027183 182 1 0 0 0 0 0 0 0 0 0 0
Totale 4.101